Sini Li
Overview
Explore the profile of Sini Li including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
264
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yuan L, Li S, Zhu Y, Yang L, Zhang X, Qu Y, et al.
EBioMedicine
. 2025 Jan;
112:105515.
PMID: 39808946
Background: Small cell lung cancer (SCLC) represents a highly aggressive neuroendocrine tumour with a dismal prognosis. Currently, the identification of a specific tumour antigen that can facilitate immune-based therapies for...
2.
Wu M, Ma J, Wang X, Li S, Tan C, Xie O, et al.
Clin Mol Hepatol
. 2024 Dec;
PMID: 39623958
Background: The WHO set the goal of eliminating hepatitis C virus (HCV) by 2030, with 80% and 65% reductions in HCV incidence and mortality rates, respectively. We aimed to evaluate...
3.
Wu M, Ma J, Li S, Qin S, Tan C, Xie O, et al.
Pharmacoeconomics
. 2024 Sep;
42(12):1345-1357.
PMID: 39222272
Background And Objective: China has the highest number of hepatitis C virus (HCV) infections in the world. However, it is unclear what levels of screening and treatment are needed to...
4.
Liu L, Li S, Wang G, Qu Y, Wang Z, Duan J, et al.
J Natl Cancer Cent
. 2024 Jul;
3(3):186-196.
PMID: 39035191
Objective: Immune checkpoint inhibitors (ICIs) targeting programmed cell death-1/ligand-1 (PD-1/PD-L1), cytotoxic T lymphocyte antigen-4 (CTLA-4), and lymphocyte-activation gene-3 (LAG-3) have been widely studied and applied throughout the course of cancer...
5.
Yi L, Chen J, Li S, Cui W, Li J, Peng L, et al.
J Psychiatr Res
. 2024 Jun;
176:205-212.
PMID: 38878648
Background: Combinations of Chinese patent medicines (CPM) with antidepressants (including selective serotonin reuptake inhibitors (SSRI), selective serotonin-norepinephrine reuptake inhibitors (SNRI), tricyclic antidepressants (TCA), and noradrenergic and specific serotonergic antidepressants (NaSSA))...
6.
Yang J, Chen Y, Tian Y, Li X, Yu Q, Huang C, et al.
Int J Ment Health Nurs
. 2024 Apr;
33(5):1197-1211.
PMID: 38622945
Mental health problems in nurses are prevalent and impairing. To date, no literature has comprehensively synthesised cohort evidence on mental health among nurses. This scoping review aimed to synthesise the...
7.
Qin S, Wang X, Li S, Wu M, Wan X
Prev Med
. 2024 Jan;
179:107851.
PMID: 38191061
The benefits of gastric cancer screening are related to age and comorbidity status, but reliable estimates are lacking in China. This study aimed to estimate the benefits and affordability of...
8.
Li S, Qu Y, Liu L, Zhang X, He Y, Wang C, et al.
Cell Biosci
. 2023 Sep;
13(1):180.
PMID: 37770976
Background: Metastases within liver or the brain are the most common causes of mortality from lung cancer (LC). Predicting liver or brain metastases before having evidence from imaging of the...
9.
Liu L, Li S, Qu Y, Bai H, Pan X, Wang J, et al.
Cell Rep Med
. 2023 Sep;
4(10):101206.
PMID: 37769655
Immunophenotyping of the tumor microenvironment (TME) is essential for enhancing immunotherapy efficacy. However, strategies for characterizing the TME exhibit significant heterogeneity. Here, we show that endoplasmic reticular oxidoreductase-1α (ERO1A) mediates...
10.
Li S, Chen Z, Yong Y, Xie J, Li Y
Compr Psychiatry
. 2023 Sep;
127:152426.
PMID: 37757593
Purpose: To evaluate the effectiveness of ACT-based interventions on improving the mental health of parents of children with SHCN compared to active/inactive controls and to investigate the characteristics/components of the...